loading
Schlusskurs vom Vortag:
$39.34
Offen:
$39.39
24-Stunden-Volumen:
53,521
Relative Volume:
0.16
Marktkapitalisierung:
$3.00B
Einnahmen:
$13.17M
Nettoeinkommen (Verlust:
$-199.06M
KGV:
-16.05
EPS:
-2.49
Netto-Cashflow:
$-156.53M
1W Leistung:
-4.14%
1M Leistung:
-9.48%
6M Leistung:
+2.67%
1J Leistung:
+33.27%
1-Tages-Spanne:
Value
$38.71
$40.20
1-Wochen-Bereich:
Value
$37.34
$41.42
52-Wochen-Spanne:
Value
$28.20
$50.99

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
Firmenname
Xenon Pharmaceuticals Inc
Name
Telefon
(604) 484-3300
Name
Adresse
200 - 3650 GILMORE WAY, BURNABY
Name
Mitarbeiter
259
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
XENE's Discussions on Twitter

Vergleichen Sie XENE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
XENE 40.08 3.00B 13.17M -199.06M -156.53M -2.49
VRTX 445.82 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.34 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.04 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.89 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.89 24.49B 3.30B -501.07M 1.03B 11.54

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-10 Fortgesetzt Raymond James Outperform
2024-10-01 Eingeleitet H.C. Wainwright Buy
2024-01-04 Eingeleitet Citigroup Buy
2023-12-08 Eingeleitet Robert W. Baird Outperform
2023-10-24 Fortgesetzt Cantor Fitzgerald Overweight
2023-04-25 Eingeleitet Cantor Fitzgerald Overweight
2022-12-14 Eingeleitet Goldman Buy
2022-12-12 Eingeleitet Cowen Outperform
2022-11-28 Eingeleitet Wells Fargo Overweight
2022-10-19 Eingeleitet Raymond James Outperform
2022-08-29 Eingeleitet BofA Securities Buy
2022-07-21 Eingeleitet JP Morgan Overweight
2021-10-28 Eingeleitet RBC Capital Mkts Outperform
2020-10-02 Eingeleitet SVB Leerink Outperform
2020-07-21 Eingeleitet Needham Buy
2020-06-01 Fortgesetzt Jefferies Buy
2020-03-25 Eingeleitet Wedbush Outperform
2020-01-08 Eingeleitet William Blair Outperform
2019-09-20 Eingeleitet Guggenheim Buy
2018-08-08 Bestätigt Stifel Buy
2017-03-13 Eingeleitet Jefferies Buy
2016-10-21 Eingeleitet Stifel Buy
2016-09-26 Eingeleitet Guggenheim Buy
2016-04-14 Bestätigt Jefferies Buy
2015-10-30 Fortgesetzt Jefferies Buy
2014-12-02 Eingeleitet Canaccord Genuity Buy
Alle ansehen

Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten

pulisher
Nov 19, 2024

First Turn Management LLC Sells 14,658 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Investors Eye Opportunities With Xenon Pharmaceuticals - Evrim Ağacı

Nov 18, 2024
pulisher
Nov 18, 2024

Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap DownHere's What Happened - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Equities Analysts Issue Forecasts for XENE FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

FY2024 EPS Estimates for XENE Reduced by Cantor Fitzgerald - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

How to Take Advantage of moves in (XENE) - Stock Traders Daily

Nov 16, 2024
pulisher
Nov 15, 2024

Q1 Earnings Forecast for XENE Issued By HC Wainwright - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

What is Wedbush's Estimate for XENE FY2024 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Leerink Partnrs Has Pessimistic View of XENE FY2024 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Needham & Company LLC Reaffirms Buy Rating for Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Stock Traders Purchase Large Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

GSA Capital Partners LLP Purchases 30,830 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

Xenon to Present at Upcoming Investor Conferences - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Xenon Pharmaceuticals (NASDAQ:XENE) Announces Quarterly Earnings Results - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Needham & Company LLC Reaffirms "Buy" Rating for Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Xenon Pharmaceuticals: Q3 Earnings Snapshot - mySA

Nov 13, 2024
pulisher
Nov 13, 2024

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlight - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Xenon Pharmaceuticals Reports Q3 2024 Progress and Outlook - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Xenon Reports Q3 2024 Financial Results and Business Update - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Xenon Pharmaceuticals Reports $803M Cash Position, Advances Epilepsy Drug Pipeline | XENE Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2 - GuruFocus.com

Nov 11, 2024
pulisher
Nov 10, 2024

TimesSquare Capital Management LLC Purchases 23,800 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Fiera Capital Corp Sells 28,679 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Nov 09, 2024
pulisher
Nov 06, 2024

Xenon Pharmaceuticals (XENE) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Xenon to Report Q3 2024 Financial Results on November 12, 2024 - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Harbor Capital Advisors Inc. Buys 23,947 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Allspring Global Investments Holdings LLC Sells 21,269 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Defense World

Nov 05, 2024
pulisher
Nov 04, 2024

New Horizons in Tonic-clonic Seizure Market Exploring Future - openPR

Nov 04, 2024
pulisher
Nov 03, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by abrdn plc - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Repligen Co. (NASDAQ:RGEN) Position Boosted by Blue Trust Inc. - Defense World

Nov 02, 2024
pulisher
Nov 02, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Rating of “Buy” by Brokerages - Defense World

Nov 02, 2024
pulisher
Nov 02, 2024

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Creative Planning - Defense World

Nov 02, 2024
pulisher
Nov 02, 2024

Creative Planning Buys 2,475 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

Nov 02, 2024
pulisher
Nov 02, 2024

Blue Trust Inc. Has $39,000 Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Nov 02, 2024
pulisher
Nov 02, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Rating of "Buy" by Brokerages - MarketBeat

Nov 02, 2024
pulisher
Oct 31, 2024

Xenon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:XENE) - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

Epilepsy Clinical Trials 2024: EMA, PDMA, FDA Approvals, - openPR

Oct 29, 2024
pulisher
Oct 29, 2024

Xenon Pharmaceuticals (NASDAQ:XENE) Shares Pass Above 50-Day Moving AverageHere's What Happened - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Assenagon Asset Management S.A. Acquires 138,685 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Oct 29, 2024
pulisher
Oct 25, 2024

When (XENE) Moves Investors should Listen - Stock Traders Daily

Oct 25, 2024
pulisher
Oct 20, 2024

SG Americas Securities LLC Sells 18,463 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Oct 20, 2024
pulisher
Oct 18, 2024

Leerink Partnrs Has Negative Outlook of XENE FY2026 Earnings - MarketBeat

Oct 18, 2024
pulisher
Oct 17, 2024

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat

Oct 17, 2024
pulisher
Oct 14, 2024

How To Trade (XENE) - Stock Traders Daily

Oct 14, 2024
pulisher
Oct 11, 2024

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe - Zacks Investment Research

Oct 11, 2024
pulisher
Oct 11, 2024

Millennium Management LLC Increases Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Xenon Pharmaceuticals Inc (XENE)’s Day in Review: Closing at 39.42, Down by -3.90 - The Dwinnex

Oct 10, 2024
pulisher
Oct 10, 2024

Raymond James sets steady target on Xenon Pharmaceuticals By Investing.com - Investing.com UK

Oct 10, 2024

Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Xenon Pharmaceuticals Inc-Aktie (XENE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
GAROFALO ELIZABETH A.
Director
Mar 08 '24
Sale
45.69
2,092
95,583
0
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Mar 07 '24
Option Exercise
9.85
8,641
85,114
16,824
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Mar 07 '24
Sale
46.28
7,137
330,290
8,398
GANNON STEVEN
Director
Mar 07 '24
Sale
46.28
13,000
601,615
2,000
AZAB MOHAMMAD
Director
Dec 19 '23
Option Exercise
9.85
4,320
42,552
74,225
PATOU GARY
Director
Dec 13 '23
Option Exercise
9.55
14,402
137,487
29,951
PATOU GARY
Director
Dec 13 '23
Sale
39.29
11,380
447,085
23,573
PATOU GARY
Director
Dec 13 '23
Sale
41.05
7,598
311,898
4,902
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):